Vasomotor Symptoms Market Size
Market Size in USD Bn
CAGR7.00%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.00% |
| Market Concentration | High |
| Major Players | Therapeutics MD, Mithra Pharmaceuticals, KaNDy Pharmaceuticals, Fervent Pharmaceuticals, Astellas Pharma and Among Others |
please let us know !
Vasomotor Symptoms Market Analysis
The Vasomotor Symptoms Market is estimated to be valued at USD 3.97 billion in 2025 and is expected to reach USD 6.37 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.00% from 2025 to 2032. The growing geriatric female population experiencing menopause worldwide is one of the key factors driving the demand for treatment of vasomotor symptoms such as hot flashes and night sweats.
The market is witnessing increased adoption of therapeutics such as Estradiol and Prempro that offer effective relief from vasomotor symptoms. Moreover, there is a rising trend of combination therapy using these drugs along with other supplements and lifestyle modifications for addressing vasomotor symptoms. With the availability of various prescription drugs and supplements, more women are seeking medical treatment for managing vasomotor symptoms triggered by menopause.